• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

作者更正：肝细胞生长因子激活剂抑制剂-2的Kunitz结构域I抑制人前列腺癌细胞的Matriptase活性和侵袭能力。

Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.

作者信息

Wu Shang-Ru, Teng Chen-Hsin, Tu Ya-Ting, Ko Chun-Jung, Cheng Tai-Shan, Lan Shao-Wei, Lin Hsin-Ying, Lin Hsin-Hsien, Tu Hsin-Fang, Hsiao Pei-Wen, Huang Hsiang-Po, Chen Chung-Hsin, Lee Ming-Shyue

机构信息

Department of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.

Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan.

出版信息

Sci Rep. 2020 Feb 13;10(1):2874. doi: 10.1038/s41598-020-60001-w.

DOI:10.1038/s41598-020-60001-w
PMID:32051516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7015910/
Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

摘要

本文的一个修订版本已发表，可通过本文顶部的链接获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5072/7015910/a301d77acbb1/41598_2020_60001_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5072/7015910/9858b329f551/41598_2020_60001_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5072/7015910/a301d77acbb1/41598_2020_60001_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5072/7015910/9858b329f551/41598_2020_60001_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5072/7015910/a301d77acbb1/41598_2020_60001_Fig2_HTML.jpg

相似文献

1
Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.作者更正：肝细胞生长因子激活剂抑制剂-2的Kunitz结构域I抑制人前列腺癌细胞的Matriptase活性和侵袭能力。
Sci Rep. 2020 Feb 13;10(1):2874. doi: 10.1038/s41598-020-60001-w.
2
HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase.HAI-2可稳定、抑制并调节胃蛋白酶原激活酶的SEA切割依赖性分泌转运。
Traffic. 2017 Jun;18(6):378-391. doi: 10.1111/tra.12482. Epub 2017 May 2.
3
Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator.缺少第一个库尼茨结构域的小鼠肝细胞生长因子（HGF）激活剂抑制剂2可有效抑制HGF激活剂。
Biochem Biophys Res Commun. 2002 Jan 25;290(3):1096-100. doi: 10.1006/bbrc.2001.6313.
4
Author Correction: Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors.作者更正：抗血管生成剂——DMXAA与低氧诱导因子-1α抑制剂——地高辛联合使用可抑制黑色素瘤肿瘤生长。
Sci Rep. 2020 Mar 25;10(1):5698. doi: 10.1038/s41598-020-62440-x.
5
Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2.
FEBS Lett. 1998 Sep 25;436(1):111-4. doi: 10.1016/s0014-5793(98)01105-3.
6
A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.一种用于人类前列腺腺癌分期的新型生物标志物：膜型丝氨酸蛋白酶过表达并伴随其抑制剂肝细胞生长因子激活剂抑制剂-1缺失
Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):217-27. doi: 10.1158/1055-9965.EPI-05-0737.
7
Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.作者更正：在前列腺癌中使用多激酶抑制剂AUM302以及AZD - 1208和BEZ235联合靶向PIM和PI3K/mTOR 。
Sci Rep. 2020 Nov 11;10(1):19870. doi: 10.1038/s41598-020-76679-x.
8
Author Correction: Anticancer polymers designed for killing dormant prostate cancer cells.作者更正：设计用于杀死休眠前列腺癌细胞的抗癌聚合物。
Sci Rep. 2019 Nov 25;9(1):17455. doi: 10.1038/s41598-019-53859-y.
9
Author Correction: Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis.作者更正：肝星状细胞分泌趋化因子Ccl5以诱导肝细胞脂肪变性。
Sci Rep. 2020 Jun 19;10(1):10284. doi: 10.1038/s41598-020-67553-x.
10
Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.作者更正：FOXA1突变改变先锋活性、分化及前列腺癌表型。
Nature. 2020 Sep;585(7826):E20. doi: 10.1038/s41586-020-2678-x.